Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Perinatal glucocorticosteroid therapy: time for reconsideration].

P Groneck1

  • 1Neonatologie und pädiatrische Intensivmedizin, Kliniken der Stadt Köln, Kinderkrankenhaus, Köln, Germany.

Zeitschrift Fur Geburtshilfe Und Neonatologie
|December 18, 2001
PubMed
Summary

Antenatal corticosteroids reduce preterm infant mortality and respiratory issues. However, multiple courses and postnatal steroid use for bronchopulmonary dysplasia may harm brain development and increase cerebral palsy risks.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

[Neonatal enterovirus meningitis: transmission via parents during rooming-in and current epidemiology in Germany].

Zeitschrift fur Geburtshilfe und Neonatologie·2011
Same author

[Recommendations on the structural prerequisites for perinatal care in Germany].

Zeitschrift fur Geburtshilfe und Neonatologie·2006
Same author

[Pharmacological prophylaxis and treatment of bronchopulmonary dysplasia].

Zeitschrift fur Geburtshilfe und Neonatologie·2005
Same author

Association of histologic chorioamnionitis, increased levels of cord blood cytokines, and intracerebral hemorrhage in preterm neonates.

Biology of the neonate·2003
Same author

Procollagen I C-propeptide in the cerebrospinal fluid of neonates with posthaemorrhagic hydrocephalus.

Archives of disease in childhood. Fetal and neonatal edition·2002
Same author

Bronchoalveolar inflammation following airway infection in preterm infants with chronic lung disease.

Pediatric pulmonology·2001

Area of Science:

  • Neonatal care
  • Pharmacology
  • Developmental neuroscience

Background:

  • Glucocorticosteroids are used to reduce pulmonary morbidity in preterm neonates.
  • Antenatal corticosteroids improve survival and reduce respiratory distress syndrome and intraventricular hemorrhage.
  • Concerns exist regarding potential adverse neurodevelopmental effects of multiple antenatal courses.

Purpose of the Study:

  • To review the benefits and risks of antenatal and postnatal glucocorticosteroid administration in preterm neonates.
  • To evaluate the long-term neurodevelopmental consequences of corticosteroid exposure.
  • To provide guidance on the appropriate use of postnatal steroids for bronchopulmonary dysplasia.

Main Methods:

  • Literature review of studies on antenatal and postnatal glucocorticosteroid use in preterm infants.

Related Experiment Videos

  • Analysis of data on mortality, pulmonary morbidity, and neurodevelopmental outcomes.
  • Comparison of different corticosteroid agents, such as betamethasone and dexamethasone.

    • Main Results:

    • One course of antenatal corticosteroids is associated with decreased mortality and improved respiratory outcomes.
    • Multiple courses of antenatal corticosteroids may be linked to impaired brain development.
    • Postnatal dexamethasone treatment for bronchopulmonary dysplasia is associated with an increased rate of cerebral palsy.

    Conclusions:

    • Antenatal corticosteroids are beneficial for preterm neonates, but long-term neurodevelopmental follow-up is crucial.
    • The use of betamethasone may offer advantages over dexamethasone.
    • Postnatal steroid use for bronchopulmonary dysplasia should be reserved for severe, life-threatening cases due to risks of cerebral palsy.